top of page

2022

European Society for Medical Oncology ESMO Congress 2022

Sept 9-13, 2022

Location: Paris, France

Name: Miguel Garcia

Presentation Type: Poster

Title: Respiratory and cardiometabolic comorbidities and stage I-III non-small cell lung cancer (NSCLC) survival: A pooled analysis from the International Lung Cancer Consortium (ILCCO)

Name: Sabine Schmid

Presentation Type: Poster

Title: Clinical outcomes of NSCLC patients (pts) who had brain-only metastasis at time of Stage 4 diagnosis, by presence versus absence of EGFR/ALK mutations

IASLC, 2022 World Conference on Lung Cancer (WCLC)

Aug 6-9, 2022, Vienna, Austria/ Virtual

Name: Abhenil Mittal

Presentation Type: Poster

Title: Prevalence And Outcomes of EGFR Exon 20 Insertion Mutation In NSCLC: Princess Margaret Cancer Center Experience

Name: Alison Moore

Presentation Type: Poster

Title: Co-occurring Mutations, Smoking Status and Prognosis of Early-stage Resected NSCLCs with EGFR Mutations

Name: Jae Lee

Presentation Type: Poster

Title: TREATMENT PATTERNS AND OUTCOMES OF FIRST-LINE OSIMERTINIB-TREATED ADVANCED EGFR MUTATED NSCLC PATIENTS: A REAL-WORLD STUDY

Name: Jessica Petricca

Presentation Type: Poster

Title: Natural Language Processing to Abstract Preneoplastic and Incidental Pulmonary Lesions from Pathology Reports

Name: Sally Lau

Presentation Type: Poster

Title: Longitudinal symptom burden and health utility scores in patients receiving PD-1 inhibitors for metastatic NSCLC

Name: Tedi Hoxha

Presentation Type: Poster

Title: Real World Survival Outcome Analysis of Adjuvant Therapies in non-EGFR, non-ALK Early-stage Resected NSCLC

Department of Medical Oncology Research Day, Princess Margaret Cancer Centre

June 22nd

Location: Toronto, Canada

Name: Rami Ajaj

Presentation Type: Poster

Title: Developing a standardized framework for curating oncology datasets generated by manual abstraction and artificial intelligence

Name: Evan Strom

Presentation Type: Poster

Title: Cumulative incidence and Metastatic Patterns of Advanced Non-Small Cell Lung Cancer (NSCLC) Characterized by EGFR status and Histology

Medical Student Research Day, University of Toronto

Feb. 22nd

Location: Toronto, Canada

Name: Jae Lee

Presentation Type: Poster

Title: Treatment patterns and outcomes of Osimertinib-treated EGFR mutation-positive NSCLC patients: A real-world study

International Conference for Healthcare and Medical Students (ICAMs) Royal College of Surgeons in Ireland (RCSI)

Feb. 22nd

Location: RCSI, Ireland

Name: Simren Chotai

Presentation Type: Oral

Title: Real-World Sequencing of ALK-TKIs in Advanced Stage ALK-positive NSCLC patients in Canada

Associated Awards: Best Overall Oral Presentation

bottom of page